Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biomarin Pharmaceutical Inc (NASDAQ:BMRN)

99.42
Delayed Data
As of Jul 29
 +1.22 / +1.24%
Today’s Change
62.12
Today|||52-Week Range
148.30
-5.10%
Year-to-Date
Sam Isaly Swaps 3 Health Care Stocks in Second Quarter
Jul 29 / GuruFocus News - Paid Partner Content
Merck (MRK) Q2 Earnings: Will the Stock Pull a Surprise?
Jul 26 / Zacks.com - Paid Partner Content
Pfizer (PFE) Likely to Beat Earnings in Q2 Again
Jul 29 / Zacks.com - Paid Partner Content
ARIAD (ARIA) to Report Q2 Earnings: Will the Stock Surprise?
Jul 26 / Zacks.com - Paid Partner Content
BioMarin Pharmaceutical (BMRN) Jumps: Stock Rises 6.6%
Jul 28 / Zacks.com - Paid Partner Content
Vertex (VRTX) to Report Q2 Earnings: Is a Surprise in Store?
Jul 25 / Zacks.com - Paid Partner Content
Stocks Down Slightly After Fed Keeps Rate Unchanged
Jul 27 / GuruFocus News - Paid Partner Content
Amgen (AMGN) May Beat Q2 Earnings: Will the Stock Gain?
Jul 25 / Zacks.com - Paid Partner Content
Biomarin Hemophilia Gene Therapy Advances on Strong Study Results
Jul 27 / TheStreet.com - Paid Partner Content
Earnings Estimates for These 3 Biotech Giants Should Be Heading Lower -- Here's Why
Jul 19 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close98.20
Today’s open98.18
Day’s range96.17 - 99.62
Volume1,448,311
Average volume (3 months)1,662,566
Market cap$15.9B
Dividend yield--
Data as of 3:59pm ET, 07/29/2016

Growth & Valuation

Earnings growth (last year)-16.30%
Earnings growth (this year)-103.10%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+16.29%
P/E ratioNM
Price/Sales19.22
Price/Book6.60

Competitors

 Today’s
change
Today’s
% change
INCYIncyte Corp+2.09+2.37%
PRGOPerrigo Company PLC+0.31+0.34%
MDVNMedivation Inc+1.50+2.40%
JAZZJazz Pharmaceuticals...-1.85-1.21%
Data as of 4:02pm ET, 07/29/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$0.51
Annual revenue (last year)$872.2M
Annual profit (last year)-$171.8M
Net profit margin-19.70%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Jean-Jacques Bienaimé
Chief Financial Officer &
Executive Vice President
Daniel K. Spiegelman
Corporate headquarters
San Rafael, California

Forecasts

Partner Offers

Search for Jobs